Hemostatics Pharmaceuticals S.L.
PrivateLast Round
Grant
Nov 1, 2023
Total Funding Raised
$3.4M
Company Overview
Hemostatics Pharmaceuticals S.L. operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Grant round in November 2023.
Hemostatics Pharmaceuticals S.L. is a biotechnology company that develops novel antifibrinolytic agents, including its lead preclinical candidate CM-352, to reduce bleeding in life-threatening and disabling hemorrhagic conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemostatics Pharmaceuticals S.L. Comparables
Compare Hemostatics Pharmaceuticals S.L. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioxodes | 86% | |
| Cayuga Biotech | 82% | |
| Haima Therapeutics | 77% |
For institutional investors. Book with your work email.
Hemostatics Pharmaceuticals S.L. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2023 | ||||
| Seed | May 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hemostatics Pharmaceuticals S.L. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agencia Estatal de Investigación | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2023
$1.09M grant received from Agencia Estatal de Investigación.
- May 12, 2021
$2M raised in Seed round.
For institutional investors. Book with your work email.
Hemostatics Pharmaceuticals S.L. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hemostatics Pharmaceuticals S.L.'s valuation, stock price, and market status.
Is Hemostatics Pharmaceuticals S.L. a public or private company?
Hemostatics Pharmaceuticals S.L. is a private company.
What is the current stock price of Hemostatics Pharmaceuticals S.L.?
Hemostatics Pharmaceuticals S.L. is a private company, so its shares have no public market price. Caplight tracks Hemostatics Pharmaceuticals S.L.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hemostatics Pharmaceuticals S.L. worth (valuation)?
Valuation information for Hemostatics Pharmaceuticals S.L. is not publicly available.
Can I buy Hemostatics Pharmaceuticals S.L. stock?
Hemostatics Pharmaceuticals S.L. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hemostatics Pharmaceuticals S.L.'s last funding round?
Hemostatics Pharmaceuticals S.L.'s most recent funding round was Grant on November 1, 2023.
Who are the main investors in Hemostatics Pharmaceuticals S.L.?
Key investors in Hemostatics Pharmaceuticals S.L. include Agencia Estatal de Investigación.
Will Hemostatics Pharmaceuticals S.L. IPO soon?
No public IPO plans have been announced for Hemostatics Pharmaceuticals S.L..
How can I track Hemostatics Pharmaceuticals S.L. secondary market activity?
Caplight tracks bids, offers, and trades in Hemostatics Pharmaceuticals S.L.'s shares on secondary markets.